Bruker and 10x Genomics settle patent dispute
Bruker and 10x Genomics have agreed to settle a patent dispute relating to products originally developed by Nanostring, a company Bruker acquired in 2024. Under the settlement, whose financial terms have not been disclosed, the two companies have entered …